PHARMACEUTICAL INDUSTRY FACING CHALLENGES IN PORTFOLIO MANAGEMENT DEPLOYMENT STRATEGIES

New Research Underscores Need for Industry-Specific Portfolio Management Solutions

NEWPORT BEACH, Calif., May 25, 2004 – According to recent survey findings, while the pharmaceutical industry recognizes the strategic business benefits of portfolio management, companies face numerous challenges in implementing effective, results-oriented solutions. Artemis International Solutions Corporation (OTCBB: AMSI) today released survey results indicating the majority of pharmaceutical organizations are confident in the maturity of their portfolio management practices, yet over 76 percent find collecting the information needed to make effective portfolio management decisions to be highly difficult. The Artemis survey, which included 84 responding firms from pharmaceutical, biopharmaceutical, and biotechnology industries, was designed to evaluate the current portfolio management practices and challenges in the market. “The results of this survey confirmed what we’ve learned from our customers,” said Patrick Ternier, CEO and president of Artemis. “Pharmaceutical firms are further along the maturity scale then many other industries, but continue to suffer from the lack of a comprehensive, integrated framework for portfolio data management.” While over 80 percent indicated that they have a consistent way to capture projected risks, costs, benefits and the strategic value of all projects, almost 50 percent indicated that they do not have an effective process for communicating this type of portfolio information across multiple business lines, development phases and locations. Strategic planning & budgeting and project management, followed by resource management, are believed to be the most important areas for portfolio management in pharmaceutical firms. Additional findings from independent market analysis company Datamonitor support the Artemis research and show that a significant proportion of pharmaceutical companies are failing to optimize their portfolio management activities. According to Datamonitor, more than 40 percent of the executives surveyed believe their companies are failing to commit adequate time and resources to portfolio management, and another 25 percent believe their organizations have little ability to implement and execute effective portfolio management. The Datamonitor study further concludes that the ability to link portfolio management to the implementation and development of corporate strategy will be a key characteristic of tomorrow’s successful pharmaceutical companies. In response to pharmaceutical company needs, Artemis recently introduced its New Product Development solution for Pharmaceutical R&D, an enterprise portfolio management system designed to improve pipeline management processes for pharmaceutical and biotechnology firms. Customers include Actelion Pharmaceuticals Ltd and Kirin Pharmaceuticals. “A key part of the challenge is an inability to effectively integrate and drive portfolio decisions down to operational execution,” said Ternier. “Artemis has 20 years of experience working with leading pharmaceutical companies and has applied this expertise to design a portfolio management solution to meet these challenges.” Artemis’ New Product Development solution is developed on the company’s enterprise portfolio, project and resource management platform, Artemis 7. It consists of pre-configured software, field-tested process templates and standard reports that have been specifically designed for rapid implementation and return on investment in pharmaceutical and biotechnology firms.

Artemis International Solutions Corporation (OTCBB: AMSI) is one of the world’s leading providers of investment planning and control solutions that help organizations execute strategy through effective portfolio and project management. Artemis has refined 30 years experience into a suite of solutions and packaged consulting services that address the specific needs of both industry and the public sector including, IT management, new product development, program management, fleet and asset management, outage management and detailed project management. With a global network covering 44 countries, Artemis is helping thousands of organizations to improve their business performance through better alignment of strategy, investment planning and project execution. Forward Looking Statements “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company’s growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements or for prospective events that may have a retroactive effect.